ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Antiandrogen Monotherapy Market - Overview Antiandrogen Monotherapy Market, by Type (Steroidal (Cyproterone Acetate), and Nonsteroidal (Bicalutamide and Flutamide)), by Disease Indication (Prostate Cancer, Benign Prostatic Hyperplasia, Hirsutism, Hyperandrogenism, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 Antiandrogens are a class of drugs that prevent androgens such as testosterone and dihydrotestosterone (DHT) from mediating their biological effects in the body. Antiandrogens are used to treat men with prostate cancer, benign prostatic hyperplasia, pattern hair loss, hypersexuality, paraphilias, and priapism. In women and girls, antiandrogens are used to treat acne, seborrhea, hirsutism, and hyperandrogenism.
Antiandrogen monotherapy is an alternative treatment option to androgen-deprivation therapy (ADT) with surgical or pharmacological castration for metastatic prostate cancer. Surgical or pharmacological castration for metastatic prostate cancer are associated with loss of libido and impotence, and may not always be acceptable to the patient. Hence, antiandrogen monotherapy provides an alternative to castration in prostate cancer treatment, which is likely to boost growth of the antiandrogen monotherapy market over the forecast period. Browse Research Reports: https://www.coherentmarketinsights.com/ongoinginsight/antiandrogen-monotherapy-market-3810 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Antiandrogen Monotherapy Market – Dynamics The increasing approvals of new antiandrogen monotherapy drugs by regulatory authorities is expected to drive the market growth over the forecast period. For instance, in December 2019, Pfizer Inc. and Astellas Pharma Inc. received approval for a supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for XTANDI (enzalutamide), indicated for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC). Moreover, increasing prevalence of prostate cancer is likely to propel growth of the antiandrogen monotherapy market over the forecast period. According to the World Cancer Research Fund, prostate cancer is the second most common cancer diagnosed in males and fourth most common cancer occurring overall. The World Cancer Research Fund also estimated that around 1.3 million males were diagnosed with prostate cancer globally in 2018. Such high prevalence of prostate cancer is expected to increase demand for antiandrogen monotherapy in order to treat the disease. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3810 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Antiandrogen Monotherapy Market - Regional Insights On the basis of region, the antiandrogen monotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the American Society of Clinical Oncology (ASCO), around 191,930 new cases of prostate cancer is estimated to be diagnosed in the U.S., in 2020. North America holds a dominant position in the global antiandrogen monotherapy market due to increasing prevalence of prostate cancer in the region. Europe is also showcasing high growth in antiandrogen monotherapy market due to increasing prevalence of prostate cancer. According to the Cancer Research UK, around 48,487 cases of prostate cancer were reported in the U.K. during 2015-2017. Global Antiandrogen Monotherapy Market - Competitive Landscape Key players operating in the global antiandrogen monotherapy market include Pfizer Inc., Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, OSI Pharmaceuticals, Inc., Genentech Inc., Bristol-Myers Squibb Company, Novartis AG, Progenics Pharmaceuticals, Inc., ALZA Corporation, Sanofi SA, GlaxoSmithKline Plc, Amgen Inc, ANI Pharmaceuticals, Inc., and others.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3810 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved